جست‌وجوی استاد و پژوهشگر

Anxo Vidal Figueroaمشاهده پروفایل

دانشیار

• Cell cycle regulation
• Tumor biology
• Stem cell biology
• +۶ مورد دیگر

Anxo Vidal Figueroa is an Associate Professor of Physiology at the University of Santiago de Compostela, where he has been a permanent faculty member since 2008. He is affiliated with the Faculty of Medicine and Dentistry, Department of Physiology, and is part of the Center for Research in Molecular Medicine and Chronic Diseases (CIMUS). Vidal leads the "MeMoEn" (Molecular Mechanisms of Disease) research group and previously contributed to the "FIFAEC" (Physiology and Pharmacology of Chronic Diseases) group. His academic journey began with a PhD in Cell Biology from the University of Santiago de Compostela in 1997, where he completed his thesis "Functional analysis of prothymosin alpha in cell cultures" under the supervision of Dr. Fernando Domínguez Puente and Dr. M. Clara Alvarez Villamarin. From 1998 to 2003, he pursued postdoctoral research at Memorial Sloan-Kettering Cancer Center in New York, working in the Laboratory of Cell Cycle Regulation under Dr. Andrew Koff. Vidal's research program focuses on understanding the molecular mechanisms of cancer development and progression, with particular emphasis on cell cycle regulation, tumor suppressor biology, and stem cell dynamics. His laboratory employs genetically modified mouse models to investigate how cell cycle regulators control cancer initiation, tissue homeostasis, and aging processes. In recent years, his work has expanded into nanomedicine and novel therapeutic strategies for advanced cancers, particularly through nanocarrier systems and immunotherapy approaches. Analysis of his recent publications reveals a strong trend toward translational cancer research, with increasing focus on nanomedicine applications (2022-2025). His work spans molecular mechanisms of tumor suppressors, cancer stem cell biology, and the development of innovative therapeutic tools including nanoengineered drug delivery systems, silver clusters as antitumoral agents, and immunotherapeutic approaches for pancreatic and ovarian cancers. 2006 Novartis Award in Endocrine Tumor Pathology Ranked #2 nationwide in Physiology for the Spanish "Ramon y Cajal" Program (2002) As a principal investigator, Vidal has secured competitive national and international research grants, including a Retos Colaboración grant with SunRock Biopharma and current grants for immunotherapy against ovarian cancer. He has supervised 16 PhD theses and mentored numerous researchers throughout his career. His laboratory, the Cell Cycle and Oncology group at CIMUS, focuses on five main research areas: mechanisms of p27Kip1 regulation, cooperative functions of cell cycle regulators, cell cycle-independent roles of CDK inhibitors in stem cell biology, molecular relationships between reprogramming and cancer, and development of new therapeutic tools in advanced cancer.

Russell Carrمشاهده پروفایل

استاد

• Toxicology
• Neurotoxicology
• Environmental Health
• +۳ مورد دیگر

Russell Carr , PhD, is a Professor at Mississippi State University's College of Veterinary Medicine. Holding a PhD in Animal Physiology (MSU, 1994) and MS in Biological Sciences (MSU, 1990), he focuses on neurotoxicology, pesticide mechanisms, and endocannabinoid system interactions. His career spans 30+ years studying organophosphate effects on neurotransmitter systems across developmental stages. Key Research Areas: Organophosphate pesticide neurotoxicity Endocannabinoid system disruption Developmental neurochemical impacts Cross-species enzyme inhibition Recent Publications (2023-2021) reveal trends in nanochannel CBD delivery systems, chlorpyrifos-induced proteomic changes in amygdala, and multi-omics approaches to pesticide-immune interactions. Earlier works establish foundational knowledge on cholinesterase inhibition kinetics and age-dependent toxicity profiles. Notable Contributions: Elucidated mechanisms of endocannabinoid enzyme inhibition by pesticides, demonstrated neurochemical impacts of low-dose exposures, and developed comparative models across species (rodents, fish).

• Immunology
• T Cell Biology
• CD4 T Cell Memory
• +۵ مورد دیگر

Susan L. Swain is a distinguished Professor of Pathology at UMass Chan Medical School, holding multiple appointments across the T.H. Chan School of Medicine and Morningside Graduate School of Biomedical Sciences. Her academic journey spans over four decades, beginning at UCSD where she rose from Lecturer to Professor of Biology in Residence, followed by leadership roles as Director and President of the Trudeau Institute, before joining UMass Medical School in 2010. Dr. Swain's research focuses on the cellular and molecular mechanisms of CD4 T cell immunity, with particular emphasis on T cell memory formation, cytotoxic CD4 effectors, and age-related immune deficiencies. Her laboratory has made seminal contributions to understanding how memory CD4 T cells provide protection against influenza infection and how aging affects T cell function. Current research priorities include discovering new mechanisms used by memory CD4 T cells for effective immunity and defining age-associated defects to develop strategies to overcome them. Analysis of Dr. Swain's recent publications reveals a consistent focus on CD4 T cell memory checkpoints, the requirements for generating protective memory cells, and the impact of aging on immune responses. Her work demonstrates that persistent infection signals at effector checkpoints determine memory cell fates, and that age-associated B cells play critical roles in immune responses in the elderly. The research has significant implications for improving vaccine efficacy in aging populations. Among her notable honors are the NIH Merit Award (awarded twice), New York State Woman of Distinction, and the American Association of Immunologists Lifetime Achievement Award. She previously served as President of the American Association of Immunologists (2004) and has held numerous editorial positions including Deputy Editor of the Journal of Immunology. Dr. Swain actively mentors students through rotation projects focusing on CD4 T cell memory, cytotoxic CD4 effectors, and aging immunity. Her laboratory provides opportunities for postdoctoral researchers interested in T cell memory development and survival. She has served on numerous national advisory boards including the National Advisory Council on Aging (2008-2012) and the Scientific Advisory Board of the La Jolla Institute of Allergy and Immunology.

Stephen J. Formanمشاهده پروفایل

استاد

• Hematology
• Oncology
• Bone Marrow Transplantation
• +۷ مورد دیگر

Stephen J. Forman, M.D. is a Professor in the Department of Hematology & Hematopoietic Cell Transplantation and Department of Medical Oncology & Therapeutics Research at City of Hope Comprehensive Cancer Center. He serves as Director of the Hematologic Malignancies Research Institute, Principal Investigator of the Lymphoma SPORE, and Director of the T Cell Therapeutics Research Laboratory. Dr. Forman has dedicated over 45 years to advancing treatments for blood cancers and has been instrumental in dramatically improving survival rates for patients with hematologic malignancies. Dr. Forman earned his M.D. from the University of Southern California in 1974 and a B.A. in Philosophy from St. John's College in 1970. His medical training includes residency and internship at Harbor UCLA Hospital, fellowship in Hematology at LAC+USC Medical Center, and fellowship in Medical Oncology at City of Hope. Dr. Forman is an international expert in leukemia, lymphoma, and bone marrow transplantation. His research focuses on immunotherapy, particularly using T cells for cancer treatment. He has been deeply involved with translational and clinical research at City of Hope's Toni Stephenson Lymphoma Center, Cellular Immunotherapy Center, Judy and Bernard Briskin Center for Multiple Myeloma Research, and the Gehr Family Center for Leukemia Research. His work in CAR T-cell therapy has positioned him at the forefront of cellular immunotherapy for hematologic malignancies. Analysis of Dr. Forman's recent publications reveals a strong focus on advancing T cell immunotherapy, particularly CAR T-cell approaches for hematologic malignancies. His research spans from basic mechanisms of T cell function to clinical applications in leukemia, lymphoma, and myeloma. A significant portion of his work addresses challenges in immunotherapy, including antigen escape, treatment resistance, and improving the safety profile of cellular therapies. His research demonstrates a clear trajectory from laboratory discoveries to clinical implementation, reflecting his commitment to translational medicine. E. Donnall Thomas Lecture, American Society for Blood and Marrow Transplantation (2019) DKMS Mechtild Harf Science Award (2019) Dr. Forman has been a principal investigator on numerous research grants, including the Lymphoma SPORE (Specialized Programs of Research Excellence), which represents significant NIH funding for lymphoma research. As Director of the Hematologic Malignancies Research Institute and former Chair of the Department of Hematology & Hematopoietic Cell Transplantation, he has overseen extensive research programs and mentored countless clinicians and scientists. His leadership in the field is reflected in his co-editorship of "Thomas' Hematopoietic Cell Transplantation," considered the definitive textbook in the field. Dr. Forman directs the T Cell Therapeutics Research Laboratory at the Beckman Research Institute of City of Hope, where his team investigates novel approaches to harness the immune system against cancer. He is also co-leader of the Hematologic Malignancies Program within City of Hope's Comprehensive Cancer Center, coordinating a multidisciplinary team focused on improving outcomes for patients with blood cancers. His work bridges basic science and clinical application, with a particular emphasis on translating laboratory discoveries into effective treatments for patients.

Mascha van 't Woutمشاهده پروفایل

دانشیار

• Anxiety
• Brain stimulation
• Fear
• +۶ مورد دیگر

Mascha van 't Wout is an Associate Professor of Psychiatry and Human Behavior at Brown University, with affiliations at the Center for Neurorestoration and Neurotechnology (Providence VA Medical Center) and the COBRE Center for Neuromodulation (Butler Hospital). Her work bridges cognitive neuroscience, psychiatry, and neuromodulation technologies. Research Focus: Explores brain stimulation techniques (tDCS/TMS) for PTSD and schizophrenia, targeting fear extinction, emotion regulation, and decision-making circuits. Notable Grants: Rubicon Award (NWO), VA Merit Award, STTR funding (DoD), and Brown Institute for Brain Science awards. Methodological Expertise: Combines virtual reality, neuroimaging, and game theory paradigms with noninvasive brain stimulation. Collaborators: Noah Philip, Jennifer Barredo, Benjamin Greenberg, Linda Carpenter, and Audrey Tyrka. Teaching: Directed courses in cognitive neuroscience of emotion and mentored honors theses at Brown University. Scientific Awards: Rubicon Award (NWO) - Emotion-decision research Young Investigator Award (NARSAD) - tDCS for OCD VA/DoD grants for PTSD neuromodulation

Wei Caoمشاهده پروفایل

استاد

• Neuroinflammation
• Alzheimer's Disease
• Neurodegenerative Diseases
• +۷ مورد دیگر

Dr. Wei Cao is a Professor at The University of Texas Health Science Center at Houston conducting groundbreaking research at the intersection of neuroscience and immunology. His work focuses on neuroinflammation in neurodegenerative diseases, particularly Alzheimer's disease, with emphasis on the role of type I interferon pathways and microglial activation in disease pathogenesis. Dr. Cao's educational background includes a BS equivalent in Biological Science from Tsinghua University, a PhD in Biochemistry from the University of North Carolina at Chapel Hill, and postdoctoral training in Molecular Virology at The Scripps Research Institute. BS (eq) in Biological Science - Tsinghua University, Beijing, China PhD in Biochemistry - University of North Carolina at Chapel Hill Postdoctoral Fellowship in Molecular Virology - The Scripps Research Institute Dr. Cao's research program centers on understanding how neuroinflammation contributes to neurodegenerative processes, with particular focus on Alzheimer's disease. His lab discovered that type I interferon, traditionally associated with antiviral responses, plays a pathogenic role in AD by promoting synapse elimination and impairing memory performance. Current investigations explore how genomic instability and transposable element dysregulation in aging contribute to neuroinflammation, and how peripheral immune responses and environmental factors influence brain pathology. Analysis of Dr. Cao's recent publications reveals a consistent research trajectory focused on the interface between immune responses and neurodegeneration. His work spans from fundamental molecular mechanisms of interferon signaling in microglia to translational studies examining therapeutic approaches for Alzheimer's disease. The publications demonstrate expertise in both neuroscience and immunology, with increasing emphasis on the role of aging-related genomic changes in neuroinflammatory processes. Dr. Cao leads the Cao Lab and is affiliated with several research centers including the Center for Perioperative Medicine, Consortium on Aging, and Neuroscience Research Center at UTHealth Houston. His research program appears to be well-funded through multiple NIH or similar grants, though specific funding sources aren't detailed in the provided text. The lab actively investigates the connections between peripheral immune responses, environmental factors, and brain pathology in neurodegenerative conditions. Dr. Cao's laboratory is part of the broader neuroscience research ecosystem at UTHealth Houston, collaborating with researchers across multiple disciplines to understand the complex interplay between immune responses and neurodegenerative processes. His work bridges basic science and potential clinical applications, particularly in developing interventions targeting neuroinflammatory pathways in Alzheimer's disease.

James Antonyمشاهده پروفایل

استادیار

• Neuroscience
• Cognitive Psychology
• Memory Research
• +۳ مورد دیگر

James Antony is an Assistant Professor in the Department of Psychology at California Polytechnic State University. He holds a Ph.D. in Neuroscience from Northwestern University and a B.A. in Biochemistry & Music from Lawrence University. Prior to his current role, he was an Assistant Project Scientist at the University of California, Davis and a C.V. Starr Postdoctoral Fellow at Princeton University. His research explores how memories persist over time, focusing on mechanisms like sleep-mediated consolidation, reactivation during wakefulness, and the influence of factors like surprise and semantic relatedness. He employs methodologies such as behavioral experiments, neuroimaging, and computational modeling. Antony has received notable awards including the 2019 Cermak/Corkin Post-Doc Award and recognition as a 2022 Rising Star by the Association for Psychological Science. His work spans topics including targeted memory reactivation, spatial gist extraction, and the neural signatures of surprise during naturalistic viewing. Recent studies highlight the role of sleep spindles in memory processing and the application of closed-loop stimulation techniques. His research has been published in journals like Neuron , Current Biology , and Science . Antony advises students on projects involving memory reactivation and learning strategies, reflecting his commitment to integrating undergraduate research into cognitive neuroscience inquiries.

Anna Orrمشاهده پروفایل

استادیار

• Neuroscience
• Neurodegenerative Disorders
• Glial-Neuronal Interactions
• +۳ مورد دیگر

Anna Orr is an Assistant Professor at Weill Cornell Medicine's Graduate School of Medical Sciences and holds the Nan and Stephen Swid Endowed Professorship of Frontotemporal Dementia Research. The Orr lab investigates glial-neuronal interactions with a focus on astrocytes and mitochondria as therapeutic targets for neurocognitive impairments in FTD, AD, and related disorders. Emory University (PhD in Neuroscience) Gladstone Institutes/UCSF (Postdoctoral Research Fellow) Research interests include: Mechanisms of glial-neuronal interactions in neurodegenerative diseases Mitochondrial reactive oxygen species (ROS) production and regulation Sex-specific cognitive modulation via astrocytic receptor signaling Antiviral pathway disruptions in dementia Translational approaches using transgenic models and omic technologies Therapeutic targeting of neuroimmune and redox pathways Notable article trends: Sex-dimorphic effects of astrocytic receptors on memory Neuroimmune signaling in nucleocytoplasmic disruptions TDP-43 pathology in astrocyte antiviral pathways Mitochondrial ROS contributions to dementia pathology Multi-omics approaches to identify therapeutic targets Scientific awards: 2021 Outstanding Neuroscience Teaching and Mentoring Award 2021 Nan and Stephen Swid Endowed Professorship Accelerating Drug Discovery for FTD Grant (AFTD/ADDF) Lab members include graduate students Daniel Barnett (Glial biology), Laraib Ijaz (Gliopathophysiology), Caroline Booraem (Oxidative stress), Evelyn Hardin (Neuroimmune interactions), Alicia Whye (GPCR roles in memory), and postdoctoral researchers Minwoo Wendy Jang and Pedro Negri Bernardino. The lab is part of the Brain and Mind Research Institute and collaborates with the Appel Alzheimer's Disease Research Institute.

Analisa DiFeoمشاهده پروفایل

دانشیار

• Ovarian Cancer
• miRNA Regulation
• Cancer Biology
• +۵ مورد دیگر

Analisa DiFeo, Ph.D., serves as Associate Professor in the Department of Pathology and Obstetrics and Gynecology at the University of Michigan Medical School. Her research program, based at Michigan Medicine, focuses on molecular mechanisms of ovarian cancer development and progression through interdisciplinary collaboration within the university's extensive research ecosystem. Dr. DiFeo's laboratory investigates microRNA regulation and gene expression in ovarian tumor biology using integrated in vitro and in vivo approaches. Her research spans molecular oncology, cancer signaling pathways, and tumor microenvironment interactions, with particular emphasis on PP2A signaling, miR-181a function, and mechanisms of platinum resistance in high-grade serous ovarian carcinoma. Her team develops patient-derived models and mouse systems to dissect oncogenic processes and identify therapeutic vulnerabilities. Analysis of her 15 most recent publications (2024-2025) reveals consistent focus on gynecologic cancers, especially ovarian and uterine malignancies. Key research themes include PP2A tumor suppressor reactivation, miRNA-driven oncogenesis, tumor microenvironment dynamics, and development of novel therapeutic strategies targeting molecular dependencies in treatment-resistant disease. Her work bridges basic molecular mechanisms with translational applications. Dr. DiFeo actively mentors students in her laboratory, emphasizing hands-on training in molecular biology techniques, cancer genetics, and mouse modeling. She encourages passionate students to seek research opportunities through direct inquiry, providing comprehensive training in wet lab methodologies, tissue culture, and development of patient-derived cancer models. Her lab fosters collaborative problem-solving for complex oncology challenges. The DiFeo Laboratory operates within the Center for RNA Biomedicine at the University of Michigan, leveraging institutional resources for RNA-focused cancer research. Her team collaborates across disciplines to investigate microRNA functions in tumor initiation, progression, and therapeutic resistance, utilizing advanced models including tumoroids and genetically engineered systems to mimic clinical disease phenotypes.

• Visual Search
• Visual Attention
• Methodology
• +۳ مورد دیگر

Johan Hulleman is a Senior Lecturer at the University of Manchester's Division of Psychology Communication and Human Neuroscience. His research focuses on Visual Search, Visual Attention, and Methodology. He holds a PhD in Experimental Psychology from the University of Nijmegen (The Netherlands) and a BSc in Medical Biology from the University of Utrecht. Education: PhD in Experimental Psychology, University of Nijmegen BSc in Medical Biology, University of Utrecht Research interests include exploring how visual attention operates in complex tasks, error mechanisms in search processes, and the application of transcranial electrical stimulation (tES) to enhance cognitive performance. His work contributes to the UN Sustainable Development Goals by advancing understanding of neurological conditions like neurofibromatosis type 1 through electrophysiological studies. Recent articles highlight stochastic error analysis in visual search, cross-cultural reading direction effects, and meta-analyses of tES applications. Collaborations include projects with the University of Liverpool and Vrije Universiteit Amsterdam. He co-led the 'Application of Novel Techniques to Enhance Cognitive Performance' project (2020–2023), focusing on transcranial electrical stimulation. Teaching includes courses on psychological statistics and conceptual issues in psychology.

Bill B. Messerمشاهده پروفایل

استادیار

• Virology
• Immunology
• Infectious Diseases
• +۳ مورد دیگر

William B. Messer is an Assistant Professor in the Department of Medicine at Oregon Health & Sciences University (OHSU), with a focus on virology and immunology. Previously, he was a Clinical Assistant Professor at the University of North Carolina (UNC) School of Medicine. His research emphasizes dengue virus genetics, alphavirus pathogenesis, and immune responses to SARS-CoV-2. He holds an M.D. and Ph.D. from UNC, where his doctoral work investigated dengue virus evolution in Sri Lanka. Education: Ph.D., Ecology, University of North Carolina at Chapel Hill, 2003 M.D., University of North Carolina School of Medicine, 2006 Residency in Internal Medicine, UNC Hospitals, 2009 Fellowship in Infectious Diseases, UNC School of Medicine, 2012 Research Interests: Dr. Messer studies viral evolution, immune responses to flaviviruses (e.g., dengue, Zika), and vaccine development. His work includes multi-omic profiling of immune dysregulation in viral infections and antibody dynamics in SARS-CoV-2. His lab explores viral genetics and host-pathogen interactions, with implications for public health and clinical interventions. Publications: His work spans high-impact journals, focusing on viral pathogenesis, vaccine efficacy, and immune correlates of disease severity. Recent studies include analyses of SARS-CoV-2 antibody responses and cross-neutralizing immunity against alphaviruses. Labs/Teams: Collaborates with OHSU and international teams on viral research, including projects on dengue epidemiology and SARS-CoV-2 diagnostics.

• Immunology
• Infectious Disease
• Pediatrics
• +۴ مورد دیگر

Professor Ann Moormann is a leading academic at UMass Chan Medical School in the Department of Medicine , with joint appointments across multiple graduate programs in biomedical sciences. Her research focuses on the intersection of pediatric immunology , malaria , and Epstein-Barr virus (EBV) in driving endemic Burkitt lymphoma (eBL) in sub-Saharan Africa. Education : BA in French & Microbiology (University of Minnesota), MPH (University of Michigan), PhD in Philosophy (University of Michigan). Dr. Moormann’s work explores how chronic malaria exposure impairs EBV-specific T-cell immunity, leading to eBL, and investigates cytokine regulation (e.g., IL-15, PD-1 pathway) and Th17 cell responses in co-infections. Recent publications highlight her leadership in malaria immunology , viral oncogenesis , and epidemiological modeling , with collaborations spanning Kenya, Congo, and Zanzibar. Current projects include avatar mouse models for eBL heterogeneity and serological tools for global health equity during pandemics. She leads studies on non-invasive biomarkers for eBL survival and mentors African oncology researchers.

Gerardo G. Piroliمشاهده پروفایل

عضو هیئت علمی

• Mitochondrial Diseases
• Protein Succination
• Metabolic Regulation
• +۷ مورد دیگر

Gerardo G. Piroli is a Research Assistant Professor in the Department of Pharmacology, Physiology & Neuroscience at the University of South Carolina School of Medicine. His research focuses on protein succination in the context of mitochondrial diseases such as Leigh syndrome, with a particular interest in how metabolic stress impacts cellular function. Ph.D. in Biochemistry and Physiology, University of Buenos Aires School of Pharmacy and Biochemistry Postdoctoral Training, The Rockefeller University and University of Buenos Aires B.Sc. in Biochemist and Pharmacist, University of Buenos Aires School of Pharmacy and Biochemistry Dr. Piroli's research centers on the irreversible post-translational modification of proteins known as succination, which occurs when fumarate reacts with cysteine residues. His work has shown that the voltage-dependent anion channel (VDAC) is a key target of succination in the brain of the Ndufs4 KO mouse model of Leigh syndrome, potentially exacerbating mitochondrial dysfunction. He is currently exploring therapeutic interventions such as antioxidants and alternative electron carriers to reduce succination and improve outcomes in mitochondrial disorders. His recent publications highlight trends in mitochondrial and metabolic stress, protein modifications, neurodegeneration, and endocrine regulation. Research spans from fundamental biochemistry to disease models, including diabetes, cancer, and stress-related neuropsychiatric conditions. Scientific contributions include: Identification of tubulin as a novel succinated protein Linking mitochondrial stress to ER stress in adipocytes Exploring fumarase deficiency in Mycobacterium tuberculosis Investigating insulin resistance in hippocampal function Dr. Piroli is actively involved in teaching medical and graduate students, covering pharmacology, physiology, and biochemical basis of disease. He leads small group discussions and lectures on topics including antimicrobials, metabolic integration, signal transduction, and the HPA axis. While no formal advisees are listed, his lab work under Dr. Norma Frizzell suggests mentorship of junior researchers. He has not received publicly listed awards, but his sustained publication record and interdisciplinary research indicate significant scientific impact. His work is conducted within the Basic Science Building at the University of South Carolina School of Medicine, where he contributes to a collaborative environment focused on understanding the molecular basis of metabolic and neurological diseases.

• Polymer Science
• Nanomaterials
• Block Copolymer Self-Assembly
• +۱۳ مورد دیگر

Ulrich (Uli) Wiesner is the Spencer T. Olin Professor of Engineering in the Department of Materials Science and Engineering at Cornell University's College of Engineering. He has been a faculty member since 1999, starting as a tenured Associate Professor and becoming a Full Professor in 2005. Since 2015, he has co-directed the MSKCC-Cornell Center for Translation of Cancer Nanomedicine (MC2TCN), a National Cancer Institute (NCI)-funded Center for Cancer Nanotechnology Excellence. Ph.D., Physical Chemistry, University of Mainz and Max-Planck-Institute for Polymer Research (1991) Diploma, Chemistry, Johannes Gutenberg University of Mainz (1988) Wiesner’s research lies at the interface of polymer science and inorganic chemistry, focusing on the self-assembly of block copolymers to create multifunctional hybrid nanomaterials. His group pioneers the use of soft matter principles to encode hierarchical structure in inorganic materials, enabling the design of materials with no natural analogues. Key areas include mesoporous oxides and non-oxides for energy applications, and the development of ultrasmall fluorescent core-shell silica and aluminosilicate nanoparticles (C-dots) for bioimaging and nanomedicine. The 15 most recent publications reveal a strong trend toward quantum materials , cancer nanotherapeutics , and super-resolution imaging . His team leverages block copolymer self-assembly to create gyroidal and diamond network nanostructures for superconducting metamaterials, while simultaneously advancing clinical translation of nanoparticles for targeted drug delivery and ferroptosis-based cancer therapy. The integration of soft matter with hard condensed matter is a unifying theme across energy, quantum, and biomedical applications. His scientific awards include: National Academy of Inventors (NAI) Fellow (2024) Ambassadeur pour la Chimie Française, CNRS (2019) Arthur K. Doolittle Award, ACS PMSE (2016) Elected PMSE Fellow, American Chemical Society (2015) National Science Foundation Creativity Award (2008) Mr. & Mrs. Richard F. Tucker’50 Excellence in Teaching Award, Cornell (2005) IBM Faculty Partnership Award (2001) Carl Duisberg Memorial Award, GDCh (1999) Wiesner has secured significant funding from the NCI and other federal agencies to support his interdisciplinary research. His group mentors students across chemistry, materials science, and biomedical engineering, contributing to advances in nanoparticle synthesis , clinical translation , and multifunctional material design . He leads a dynamic research team working at the forefront of cancer nanotechnology and quantum metamaterials , with future work focused on expanding the clinical impact of nanotherapeutics and exploring emergent phenomena in soft-matter-directed quantum systems.

Haike Antelmannمشاهده پروفایل

استاد

• Oxidative Stress Physiology
• Redox Biology
• Bacterial Pathogens
• +۳ مورد دیگر

Prof. Dr. Haike Antelmann holds the W3-Professorship for Molecular Microbiology at the Institute of Biology-Microbiology, Freie Universität Berlin since 2015. She previously served as group leader at the Ernst-Moritz-Arndt-University of Greifswald (2006-2015) and completed her Habilitation there in 2009. Her research focuses on microbial redox biology, thiol-based stress responses in Gram-positive pathogens like Staphylococcus aureus and Streptococcus pneumoniae , and proteomic analysis of bacterial adaptation mechanisms. Key contributions include elucidating bacillithiol/mycothiol roles in protein protection and redox signaling. Education: PhD (1998) and Habilitation (2009) from Ernst-Moritz-Arndt-University Greifswald, specializing in bacterial proteomics and stress physiology. Notable awards include the ERC Consolidator Grant (2013) and AcademiaNet membership (2015). She serves on editorial boards of BMC Microbiology , Molecular Microbiology , and Scientific Reports . Research interests emphasize thiol-redox regulation in pathogenesis, including protein S-thiolation under oxidative/electrophilic stress and bacterial responses to host immune defenses. Her lab investigates bacillithiol's role in virulence and antibiotic tolerance, with recent work on allicin mechanisms and neutrophil phagosome interactions. Lab members: Postdocs (Eberhard Klauck, Vu Van Loi), PhD students (Huihui Li), and technical staff (Zeynep Gümüsboga) Key techniques: Proteomics, redox biosensors, transcriptomics, bacterial physiology studies Collaborations: GBM Study Group on Redox Biology, SPP1710 projects Recent articles highlight Staphylococcus aureus adaptation to host-derived stressors (hypothiocyanous acid, itaconic acid) and mechanisms of antimicrobial resistance. Her work bridges basic microbiology with translational applications in infectious disease intervention.